RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
This Quarter Return
+7.85%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.76B
AUM Growth
+$1.76B
(+0.1%)
Cap. Flow
-$67.8M
Cap. Flow
% of AUM
-3.85%
Top 10 Holdings %
Top 10 Hldgs %
24.81%
Holding
276
New
14
Increased
59
Reduced
180
Closed
14
Top Buys
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$13.2M |
| 2 |
Eventbrite
EB
|
$11.8M |
| 3 |
Establishment Labs
ESTA
|
$9.29M |
| 4 |
PROS Holdings
PRO
|
$7.79M |
| 5 |
Pacira BioSciences
PCRX
|
$6.54M |
Top Sells
| 1 |
Semtech
SMTC
|
$13.7M |
| 2 |
Medifast
MED
|
$11.8M |
| 3 |
Premier
PINC
|
$10.7M |
| 4 |
Medpace
MEDP
|
$8.27M |
| 5 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$6.5M |
Sector Composition
| 1 | Healthcare | 28.23% |
| 2 | Technology | 24.61% |
| 3 | Industrials | 19.11% |
| 4 | Consumer Discretionary | 9.18% |
| 5 | Communication Services | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Establishment Labs
ESTA
$1.2B
| $17.9M | 1.02% | 260,966 +135,338 | +108% | +$9.29M |
|
27
Vail Resorts
MTN
$6.09B
| $17.9M | 1.02% | 71,116 -1,186 | -2% | -$299K |
|
28
Shutterstock
SSTK
$742M
| $17.8M | 1.01% | 364,976 -1,370 | -0.4% | -$66.7K |
|
29
Digital Turbine
APPS
$455M
| $17.2M | 0.97% | 1,848,924 -1,889 | -0.1% | -$17.5K |
|
30
LeMaitre Vascular
LMAT
$2.16B
| $17M | 0.96% | 252,418 -2,048 | -0.8% | -$138K |
|
31
Maximus
MMS
$4.95B
| $17M | 0.96% | 200,732 -2,416 | -1% | -$204K |
|
32
Supernus Pharmaceuticals
SUPN
$2.53B
| $16.7M | 0.95% | 554,793 +3,508 | +0.6% | +$105K |
|
33
Pool Corp
POOL
$11.6B
| $16.6M | 0.94% | 44,397 -842 | -2% | -$315K |
|
34
Ascendis Pharma
ASND
$11.8B
| $15.5M | 0.88% | 173,463 +18,535 | +12% | +$1.65M |
|
35
Bank OZK
OZK
$5.91B
| $14.9M | 0.85% | 371,216 -6,968 | -2% | -$280K |
|
36
OmniAb
OABI
$230M
| $14.2M | 0.81% | 2,832,376 +12,274 | +0.4% | +$61.7K |
|
|
RVNC
37
DELISTED
Revance Therapeutics, Inc.
RVNC
| $14M | 0.79% | 552,495 -256,681 | -32% | -$6.5M |
|
38
Cambium Networks
CMBM
$21.5M
| $13.9M | 0.79% | 914,310 +35,937 | +4% | +$547K |
|
|
39
Eventbrite
EB
$256M
| $13.8M | 0.78% | 1,444,950 +1,235,961 | +591% | +$11.8M |
|
|
40
BioCryst Pharmaceuticals
BCRX
$1.74B
| $13.2M | 0.75% | +1,872,964 | New | +$13.2M |
|
41
Amicus Therapeutics
FOLD
$2.34B
| $13.2M | 0.75% | 1,048,663 +201,804 | +24% | +$2.53M |
|
42
Qualys
QLYS
$4.9B
| $13M | 0.74% | 100,514 -1,627 | -2% | -$210K |
|
43
Neurocrine Biosciences
NBIX
$13.8B
| $12.7M | 0.72% | 135,070 -2,167 | -2% | -$204K |
|
44
RB Global
RBA
$21.3B
| $12.4M | 0.7% | 206,647 -686 | -0.3% | -$41.2K |
|
45
Iovance Biotherapeutics
IOVA
$807M
| $12.4M | 0.7% | 1,758,759 +28,795 | +2% | +$203K |
|
46
CEVA Inc
CEVA
$531M
| $12.1M | 0.69% | 474,622 +717 | +0.2% | +$18.3K |
|
|
47
Premier
PINC
$2.14B
| $11.7M | 0.67% | 424,759 -386,583 | -48% | -$10.7M |
|
48
ReposiTrak
TRAK
$296M
| $11.2M | 0.63% | 1,108,024 +42,140 | +4% | +$425K |
|
49
Utah Medical Products
UTMD
$199M
| $10.5M | 0.6% | 112,999 -1,124 | -1% | -$105K |
|
50
Century Casinos
CNTY
$79.9M
| $9.37M | 0.53% | 1,320,114 +9,829 | +0.8% | +$69.8K |
|